rabbit polyclonal antibody against abca1 (Novus Biologicals)
Structured Review

Rabbit Polyclonal Antibody Against Abca1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 130 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit polyclonal antibody against abca1/product/Novus Biologicals
Average 94 stars, based on 130 article reviews
Images
1) Product Images from "Small GTPase ARL4C Associated with Various Cancers Affects Microtubule Nucleation."
Article Title: Small GTPase ARL4C Associated with Various Cancers Affects Microtubule Nucleation.
Journal: Biomedicines
doi: 10.3390/biomedicines12122872
Figure Legend Snippet: Figure 2. Treatment using LXR/RXR ligands does not lead to an increase in the endogenous ABCA1 or ARL4C level in many cell lines: (A) Titration of BS-C-1 lysate demonstrates that the ratio of levels of ARL4C in Vero and BS-C-1 cells is 1:4.5. (B) The level of ARL4C is not increased in both Vero and BS-C-1 cells even after 7 days of treatment with T0901317 and bexarotene. (C) LXR/RXR-dependent pathway is activated in HeLa cells and weakly activated in MCF7 cells after 48h exposure to 2.5 µM T0901317/bexarotene; however, not in Vero cells even after prolonged treatment. (D) Neither ABCA1 nor ARL4C levels increase after treatment of COS7 and U2OS cells with RXR/LXR ligands. Long-term treatment of the MCF7 cells results in only a slight increase in the ARL4C level.
Techniques Used: Titration

